Innovative Vaccine Technologies is a U.S.-based biotechnology company in Utah that develops vaccines. Its filings show it lobbies Congress for federal funding, especially Fiscal Year 2026 appropriations, to support medical and disease research and clinical lab work focused on developing a synthetic vaccine. It hires The Livingston Group to represent these funding requests.
Show the dominant industry call, how mixed the client looks, and the allocation across the top labeled sectors.
Annual totals based on disclosed filing amounts.
Issue rankings are based on disclosed activity mentions, with filing amounts apportioned evenly across issues within the same filing.
The lobbying registrants handling this client, ranked by disclosed filing amounts.
Lobbyists are ranked by appearances and an equal share of each filing's reported amount.
J ALLEN MARTIN
The latest disclosures for this client.
THE LIVINGSTON GROUP, LLC
Q1YTHE LIVINGSTON GROUP, LLC
Q4The entities named in disclosed activities are the clearest available signal for where the client is aiming attention.
This client's filings do not yet disclose named government entities.
THE LIVINGSTON GROUP, LLC
ROBERT L LIVINGSTON
THE LIVINGSTON GROUP, LLC
THE LIVINGSTON GROUP, LLC
Q3THE LIVINGSTON GROUP, LLC
Q2THE LIVINGSTON GROUP, LLC
Q1